Tenet Healthcare Statistics
Total Valuation
THC has a market cap or net worth of $20.51 billion. The enterprise value is $31.59 billion.
| Market Cap | 20.51B |
| Enterprise Value | 31.59B |
Important Dates
The last earnings date was Thursday, July 23, 2026, after market close.
| Earnings Date | Jul 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
THC has 80.52 million shares outstanding. The number of shares has decreased by -8.21% in one year.
| Current Share Class | 80.52M |
| Shares Outstanding | 80.52M |
| Shares Change (YoY) | -8.21% |
| Shares Change (QoQ) | -4.15% |
| Owned by Insiders (%) | 1.10% |
| Owned by Institutions (%) | 103.39% |
| Float | 79.52M |
Valuation Ratios
The trailing PE ratio is 9.89 and the forward PE ratio is 12.54. THC's PEG ratio is 1.01.
| PE Ratio | 9.89 |
| Forward PE | 12.54 |
| PS Ratio | 0.94 |
| Forward PS | 0.92 |
| PB Ratio | 4.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.79 |
| P/OCF Ratio | 5.11 |
| PEG Ratio | 1.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.11, with an EV/FCF ratio of 10.45.
| EV / Earnings | 14.10 |
| EV / Sales | 1.45 |
| EV / EBITDA | 6.11 |
| EV / EBIT | 7.39 |
| EV / FCF | 10.45 |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 1.52.
| Current Ratio | 1.41 |
| Quick Ratio | 1.14 |
| Debt / Equity | 1.52 |
| Debt / EBITDA | 2.56 |
| Debt / FCF | 4.38 |
| Interest Coverage | 5.21 |
Financial Efficiency
Return on equity (ROE) is 37.34% and return on invested capital (ROIC) is 16.59%.
| Return on Equity (ROE) | 37.34% |
| Return on Assets (ROA) | 8.32% |
| Return on Invested Capital (ROIC) | 16.59% |
| Return on Capital Employed (ROCE) | 17.03% |
| Weighted Average Cost of Capital (WACC) | 8.81% |
| Revenue Per Employee | $220,323 |
| Profits Per Employee | $22,636 |
| Employee Count | 99,000 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 37.65 |
Taxes
In the past 12 months, THC has paid $691.00 million in taxes.
| Income Tax | 691.00M |
| Effective Tax Rate | 17.88% |
Stock Price Statistics
The stock price has increased by +58.36% in the last 52 weeks. The beta is 1.27, so THC's price volatility has been higher than the market average.
| Beta (5Y) | 1.27 |
| 52-Week Price Change | +58.36% |
| 50-Day Moving Average | 191.89 |
| 200-Day Moving Average | 200.39 |
| Relative Strength Index (RSI) | 73.60 |
| Average Volume (20 Days) | 1,448,970 |
Short Selling Information
The latest short interest is 2.98 million, so 3.70% of the outstanding shares have been sold short.
| Short Interest | 2.98M |
| Short Previous Month | 4.06M |
| Short % of Shares Out | 3.70% |
| Short % of Float | 3.75% |
| Short Ratio (days to cover) | 2.24 |
Income Statement
In the last 12 months, THC had revenue of $21.81 billion and earned $2.24 billion in profits. Earnings per share was $25.75.
| Revenue | 21.81B |
| Gross Profit | 9.09B |
| Operating Income | 3.95B |
| Pretax Income | 3.87B |
| Net Income | 2.24B |
| EBITDA | 5.17B |
| EBIT | 4.28B |
| Earnings Per Share (EPS) | $25.75 |
Balance Sheet
The company has $2.17 billion in cash and $13.25 billion in debt, with a net cash position of -$11.08 billion or -$137.58 per share.
| Cash & Cash Equivalents | 2.17B |
| Total Debt | 13.25B |
| Net Cash | -11.08B |
| Net Cash Per Share | -$137.58 |
| Equity (Book Value) | 8.70B |
| Book Value Per Share | 57.86 |
| Working Capital | 2.26B |
Cash Flow
In the last 12 months, operating cash flow was $4.02 billion and capital expenditures -$992.00 million, giving a free cash flow of $3.02 billion.
| Operating Cash Flow | 4.02B |
| Capital Expenditures | -992.00M |
| Depreciation & Amortization | 893.00M |
| Net Borrowing | -80.00M |
| Free Cash Flow | 3.02B |
| FCF Per Share | $37.54 |
Margins
Gross margin is 41.66%, with operating and profit margins of 18.11% and 10.27%.
| Gross Margin | 41.66% |
| Operating Margin | 18.11% |
| Pretax Margin | 17.72% |
| Profit Margin | 10.27% |
| EBITDA Margin | 22.83% |
| EBIT Margin | 18.89% |
| FCF Margin | 13.86% |
Dividends & Yields
THC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.21% |
| Shareholder Yield | 8.21% |
| Earnings Yield | 10.92% |
| FCF Yield | 14.74% |
Analyst Forecast
The average price target for THC is $277.48, which is 8.91% higher than the current price. The consensus rating is "Buy".
| Price Target | $277.48 |
| Price Target Difference | 8.91% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 3.36% |
| EPS Growth Forecast (3Y) | 9.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 11, 2012. It was a reverse split with a ratio of 1:4.
| Last Split Date | Oct 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
THC has an Altman Z-Score of 1.96 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.96 |
| Piotroski F-Score | 6 |